MAOB and Parkinson disease: Pharmacological studies have shown that MAO-B plays a significant role in the development of Parkinson’s disease [11,12], and inhibitors of MAO-B help treat PD by upregulating levels of dopamine, a crucial neurotransmitter in PD pathogenesis [13,14].